Pharmacological management of low milk supply with domperidone: separating fact from fiction

Luke E Grzeskowiak and Lisa H Amir
Med J Aust 2015; 202 (6): . || doi: 10.5694/mja14.01585
Published online: 6 April 2015

To the Editor: After publication of our peer-reviewed perspective article on the safe and effective use of domperidone in the management of low milk supply,1 we are disappointed to have been informed that the Australian medicines handbook (AMH) has removed lactation stimulation as a recognised off-label indication for domperidone (as well as metoclopramide). It appears that this change could be a kneejerk response to recent regulatory warnings, despite these being highlighted as not being of relevance to most breastfeeding women.1,2 These changes carry with them the significant potential to create confusion among prescribers and the public.

  • Luke E Grzeskowiak1
  • Lisa H Amir2

  • 1 University of Adelaide, Adelaide, SA.
  • 2 La Trobe University, Melbourne, VIC.


Luke Grzeskowiak acknowledges salary support from a National Health and Medical Research Council Australian Public Health Fellowship (ID1070421).

Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.